Haploid Induction Technology for Seed Breeding Market Size & Share 2026-2035

Haploid Induction Technology for Seed Breeding Market Size

The global haploid induction technology for seed breeding market was valued at USD 460 million in 2025. It is projected to grow from USD 506.5 million in 2026 to USD 1.20 billion by 2035, representing 10.1% CAGR from 2026 to 2035, according to the latest report published by Global Market Insights Inc.

• Integration of CRISPR/Cas9 gene editing with DH platforms: The convergence of CRISPR-Cas9 gene editing with haploid induction technology systems, most notably through HI-Edit and In Planta Meristem Gene Editing (IMGE) platforms, is creating a high-value, fast-growing technology subcategory within the market. This integration enables the production of non-transgenic, precision-edited inbred lines within a single generation, radically compressing conventional multi-year plant breeding timelines and opening new commercial pathways for trait introgression at scale.
• Outsourcing shift to contract DH service providers: Commercial seed companies are accelerating the outsourcing of DH line production to specialist third-party DH service providers, shifting away from capital-intensive in-house DH laboratory infrastructure. This structural transition is reducing fixed cost overheads for major seed companies while simultaneously creating a high-growth market segment for contract DH service operators, reflected in the 13.2% CAGR projected for DH Contract Service Providers through 2035.
• Crop coverage expansion beyond maize: DH technology adoption is expanding rapidly beyond its established base in maize into wheat, rice, Brassica vegetables, and oilseeds, broadening the addressable market both agronomically and geographically. New protocol breakthroughs in microspore culture for wheat and anther culture for rice are unlocking large, previously untapped crop segments and driving geographic expansion into Asia Pacific and Latin America, where cereal and rice breeding programs constitute dominant agricultural research priorities.
• Innovation in safer doubling agents and digital screening tools: Manufacturers of DH screening tools and chromosome doubling agents are investing in safer, more scalable alternatives to colchicine, including nitrous oxide (N₂O) and anti-microtubule herbicides, while AI-driven digital haploid identification systems using image analysis and genomic marker platforms are gaining commercial traction. These innovations are reducing regulatory compliance challenges, improving protocol efficiency across diverse crop types, and lowering the barriers to DH adoption for mid-sized and emerging-market seed companies.

Haploid Induction Technology for Seed Breeding Market Trends

• CRISPR-DH integration accelerates precision breeding: The accelerating commercial integration of DH platforms with CRISPR-based gene editing is creating a transformative new technology tier within the market. The HI-Edit approach, which combines haploid induction with simultaneous CRISPR-Cas9 gene editing, enables delivery of genome-edited inbred lines in a single generation without transgenic modification. This convergence is attracting heightened investment from large commercial seed companies seeking regulatory-compatible precision breeding tools, representing the fastest-growing subsegment with a 19.2% CAGR for Gene Editing-Enabled HI through 2035. Major players including Corteva Agriscience and Syngenta AG are actively integrating HI-Edit workflows into their maize breeding pipelines, with further expansion into canola and vegetable crops anticipated over the forecast period.
• Digitalization of DH workflows transforms operational efficiency: The digitalization of haploid identification and screening workflows is materially enhancing the efficiency and scalability of DH service operations globally. AI-driven image analysis platforms, near-infrared spectroscopy tools, and flow cytometry systems are replacing labor-intensive manual ploidy verification methods, significantly reducing time and error rates in haploid identification pipelines. This digital transformation is accelerating throughput in commercial DH line production, enabling higher-capacity DH programs at lower per-unit cost. The integration of digital screening tools with breeding management software is further enhancing data traceability and decision-making across DH programs at commercial seed companies and contract service providers.
• Safer doubling agent alternatives gain commercial adoption: The chromosome doubling agent landscape is undergoing a significant transition away from colchicine toward less hazardous and more scalable alternatives, driven by tightening regulatory classification of colchicine as a controlled substance in multiple jurisdictions. Nitrous oxide (N₂O) treatment is gaining commercial adoption in maize and increasingly in wheat DH programs due to its lower toxicity profile, reduced regulatory burden, and comparable chromosome doubling efficiency. Anti-microtubule agents such as amiprophos-methyl (APM) are also being evaluated in controlled research programs, broadening the available toolkit for chromosome doubling across diverse crop species and germplasm types.

• CMS line acceleration via DH strengthens hybrid seed competitiveness: The application of DH technology for Cytoplasmic Male Sterility (CMS) line development is gaining significant traction in onion, sunflower, sorghum, and carrot breeding programs, where conventional CMS line fixation through inbreeding is slow and genotype-dependent. DH-accelerated CMS parent line production is reducing breeding cycle time for hybrid seed development by up to 50% compared to conventional multi-generation inbreeding methods. This efficiency advantage is driving adoption among mid-sized seed companies seeking to build competitive hybrid vegetable and field crop portfolios, creating incremental demand growth for DH services in the vegetable and specialty crop segments.

Haploid Induction Technology for Seed Breeding Market Analysis

Haploid induction technology for seed breeding market based on technology type is segmented into in vivo haploid induction, in vitro haploid induction, gene editing-enabled HI, haploid screening & ID tools, and chromosome doubling agents. The in vivo haploid induction segment was valued at USD 191.9 million in 2025, and it is anticipated to expand at a CAGR of 8.6% during 2026–2035.

• In Vivo Haploid Induction: The in vivo haploid induction segment dominates the haploid induction technology for seed breeding market due to its widespread adoption in commercial maize breeding, where maternal haploid induction using specialized inducer lines is a well-established, scalable, and cost-effective pipeline. The segment benefits from decades of protocol optimization, a broad base of trained personnel, and deep integration within seed company R&D workflows, sustaining consistent demand across North America and Europe.
• Market growth in this segment is reinforced by continuous development of improved inducer lines with higher haploid induction rates (HIR), reducing seed quantities and labor requirements per breeding cycle. New inducer lines developed through conventional and marker-assisted breeding are achieving HIRs exceeding 15–20% in adapted germplasm, substantially improving the economics of in vivo DH production and widening applicability to a broader range of maize germplasm pools.
• In Vitro Haploid Induction: In vitro haploid induction, encompassing anther culture and microspore culture techniques, retains significant commercial relevance in crops where in vivo haploid induction systems are absent or less efficient, including wheat, barley, rice, and Brassica species. The segment is undergoing renewed investment driven by expanding crop coverage objectives and protocol improvements that are increasing regeneration rates and reducing tissue culture-induced genotypic variation.
• Growth in this segment is driven by the intersection of increased demand for DH capabilities in cereal and oilseed crop improvement programs and ongoing optimization of in vitro protocols to be more genotype-independent. Microspore culture protocols for wheat are receiving heightened investment from public and private breeding programs in Europe and Asia Pacific, supported by government-funded crop improvement initiatives targeting yield and climate resilience.
• Gene Editing-Enabled HI: The gene editing-enabled haploid induction segment represents the most rapidly expanding technology category, driven by the commercial implementation of HI-Edit and IMGE platforms by leading seed companies including Corteva Agriscience. These systems leverage CRISPR-Cas9 machinery delivered through haploid inducer lines to simultaneously induce haploidy and introduce targeted genome edits, enabling precision trait development without transgenic integration.
• Regulatory clarity in the U.S. and several EU member states around the non-GMO status of SDN-1 and SDN-2 gene-edited crops is materially accelerating commercial adoption of HI-Edit technology. Seed companies are prioritizing this platform for developing drought-tolerant, disease-resistant, and yield-optimized inbred lines, with Corteva and Syngenta having disclosed active commercial pipelines leveraging this combined DH-gene editing approach.
• Haploid Screening & ID Tools: Haploid screening and identification tools, including flow cytometry systems, near-infrared spectroscopy platforms, and genomic marker-based identification kits, are critical infrastructure components in any DH pipeline and are expanding both as standalone product lines and as integrated service offerings. The segment is experiencing strong demand driven by the increasing scale and throughput requirements of commercial DH programs and the shift toward automated, high-capacity screening workflows.

• DH Line Development: DH line development constitutes the dominant application segment, representing the foundational use case for all haploid induction technology platforms across commercial and public sector breeding programs. The segment encompasses end-to-end production of fully homozygous inbred lines from heterozygous parent germplasm, delivering compressed timelines and cost efficiency relative to conventional inbreeding methods for hybrid seed development across maize, wheat, barley, sunflower, and canola.
• Demand in this segment is directly correlated with the scale of global hybrid seed development activity, which continues to expand as commercial seed companies invest in hybrid portfolios for food security crops including wheat, rice, and sorghum beyond established maize and rapeseed categories. The application of DH line development is also expanding in vegetable seed breeding, where rapid fixation of disease resistance and morphological uniformity traits provides significant commercial value to high-value seed companies.
• HI-Edit / IMGE: HI-Edit and IMGE applications are advancing from early commercial proof-of-concept into active product development pipelines at major seed companies, constituting the highest-growth application segment in the market. This platform enables simultaneous haploid induction and CRISPR-mediated genome editing, producing homozygous edited lines within a single generation without the multi-year backcrossing conventionally required to fix edited traits and eliminate transgenic elements.
• The commercial trajectory of HI-Edit applications is accelerating, with Corteva Agriscience, Syngenta, and several academic spin-offs disclosing active HI-Edit commercial programs for maize. The scalability advantage of delivering fixed edited germplasm up to five years faster than conventional approaches is positioning HI-Edit as a core strategic capability for seed companies seeking to translate genomic discoveries into commercial product pipelines rapidly.
• CMS Line Development: CMS line development using DH technology is gaining significant traction in hybrid vegetable crops including onion, carrot, sunflower, and sorghum, where CMS systems are the preferred mechanism for commercial hybrid seed production. DH-accelerated CMS parent line development enables rapid fixation of CMS and restorer lines from segregating populations, shortening parent line development cycles by up to 50% compared to conventional inbreeding.
• Growth in this application segment is supported by the expanding global market for hybrid vegetable seeds, growing at over 5% annually according to the FAO, creating sustained demand for faster and more cost-efficient CMS parent line development tools. The integration of DH technology into CMS breeding workflows is being adopted by both large multinational seed companies and mid-sized regional players targeting competitive hybrid vegetable portfolios.
• Reverse Breeding: Reverse breeding, which enables the direct fixation of outstanding hybrid genotypes into their parent components, is gaining interest among advanced plant breeding programs seeking to capture and reproduce elite heterosis without conventional parent line searches. The technique uses RNA interference to suppress meiotic recombination followed by DH line production to obtain parental lines reconstituting the original elite hybrid.
• Market development in reverse breeding is in an early-commercial phase, with adoption primarily among academic and applied research institutions and select commercial seed companies with advanced genomics capabilities. The 12% projected CAGR reflects growing technical feasibility and increasing commercial interest, particularly in highly heterotic crops such as maize and tomato where preserving elite hybrid performance delivers high strategic value.
• Synthetic Apomixis: Synthetic apomixis, which involves engineering asexual seed reproduction in sexual crop species to enable indefinite clonal propagation of elite hybrid genotypes, represents the most transformative long-term application intersecting with DH technology platforms. Recent publications demonstrating stable synthetic apomixis in rice have triggered significant investment in the technology platform, with profound implications for the entire hybrid seed industry model.

Haploid induction technology for seed breeding market based on crop type is segmented into cereals & grains, oilseeds & pulses, vegetables & specialty crops, and others. The cereals & grains segment was valued at USD 248.4 million in 2025, and it is anticipated to expand at a CAGR of 9.5% during 2026–2035.

• Cereals & Grains: Cereals and grains, particularly maize, wheat, barley, and rice, constitute the dominant crop type segment, reflecting the historical origins and most commercially mature applications of DH technology in maize inbred line development and the expanding adoption of DH protocols in wheat and barley breeding programs globally. Maize alone accounts for the largest single crop application of DH technology, with virtually all major commercial hybrid maize programs integrating DH line production as a core breeding tool.
• The cereal and grains segment is sustained by continued growth in global demand for high-yielding hybrid maize and wheat varieties driven by population growth and dietary shifts, particularly in developing economies. The opening of new DH protocols for wheat microspore culture and improvements in rice anther culture efficiency are expanding the addressable base within this segment, with Asia Pacific driving growth in rice DH applications at national breeding program scale.
• Oilseeds & Pulses: The oilseeds and pulses segment, encompassing canola/rapeseed, sunflower, and increasingly soybean and pulses, is experiencing above-average growth driven by the commercial maturity of canola DH programs in Europe and Canada and expanding DH application in sunflower. Canola haploid induction programs using microspore culture are well-established in commercial breeding operations at Bayer Crop Science, Limagrain, and KWS.
• Market development in pulses including lentils, chickpeas, and peas is at an earlier stage but is receiving increased attention from public breeding programs targeting protein crop diversification. Protocol challenges remain significant, but breakthrough results in isolated microspore culture for some pulse species are creating early commercial momentum, supported by government-funded food security programs in South Asia and Sub-Saharan Africa.
• Vegetables & Specialty Crops: The vegetables and specialty crops segment is the fastest-growing crop type category, driven by the high commercial value of DH technology for accelerating inbred and hybrid parent line development in high-value crops including pepper, tomato, onion, cucumber, and Brassica vegetables. DH adoption in vegetable seed breeding is expanding rapidly among European seed companies including Rijk Zwaan and Sakata Seed, where compressed breeding cycles deliver significant competitive advantages in time-to-market.

Haploid induction technology for seed breeding market based on end user is segmented into commercial seed companies, public research institutions, government agricultural programs, and DH contract service providers. The commercial seed companies segment was valued at USD 266.8 million in 2025, and it is anticipated to expand at a CAGR of 9.8% during 2026–2035.

• Commercial Seed Companies: Commercial seed companies constitute the dominant end user segment, representing the primary demand driver for both in-house DH infrastructure and contracted DH services. Major multinational seed companies including Corteva Agriscience, Syngenta, Bayer Crop Science, Limagrain, and KWS SAAT SE have deeply integrated DH line production into their core breeding workflows, particularly for hybrid maize, canola, sunflower, and vegetable seed development.
• Investment by commercial seed companies in DH capabilities is increasing as the technology expands beyond maize into wheat, rice, and vegetables. The strategic shift toward outsourcing DH line production to specialist contract service providers is reallocating spending from capital investment in in-house facilities to service procurement, benefiting the DH contract service segment while maintaining overall demand from commercial seed company end users.
• Public Research Institutions: Public research institutions, including international agricultural research centers (IARCs) such as CIMMYT, IRRI, and ICARDA, as well as national agricultural research systems (NARS) in major crop-producing countries, constitute a strategically significant end user base. These institutions maintain DH facilities for the production of mapping populations, breeding lines for public varietal release programs, and capacity-building resources for national breeding programs in developing countries.
• Sustained international funding for food security research through CGIAR programs and bilateral government agricultural aid is supporting the maintenance and expansion of DH capacity at public research institutions globally. The University of Hohenheim DH Program and Iowa State University DH Facility exemplify the broader network of academic DH centers contributing research advances and trained personnel to the overall market ecosystem.
• Government Agricultural Programs: Government agricultural programs, particularly national seed improvement initiatives in China, India, Brazil, and the European Union, are an emerging end user segment with above-average growth prospects driven by increasing government investment in agricultural self-sufficiency and crop improvement. These programs are commissioning DH-assisted breeding for priority food crops including wheat, rice, and sorghum as part of national food security strategies.
• China’s national crop improvement programs represent a particularly significant demand source, with state-funded breeding centers incorporating DH technology into strategic wheat and maize improvement programs aligned with national food security and agricultural modernization objectives. India’s national agricultural research system is similarly expanding DH capabilities for wheat and vegetable breeding, supported by central government funding under the National Agricultural Research and Education Policy.

• DH Contract Service Providers: DH contract service providers are the fastest-growing end user category, reflecting the structural shift of commercial seed companies toward outsourcing DH line production rather than maintaining costly in-house DH infrastructure. Specialist providers including Haplotech Inc., Fytagoras, ScreenSYS, and Procera (Romania) are scaling service capacity to meet growing outsourcing demand from both multinational and regional seed companies.

The North America haploid induction technology for seed breeding market accounted for USD 152 million in 2025 and is anticipated to show lucrative growth over the forecast period.

North America dominates the global haploid induction technology for seed breeding industry, supported by the region’s position as the world’s largest producer of hybrid maize seed and the deep institutional integration of DH technology within major commercial seed company R&D operations headquartered in the United States. Corteva Agriscience, Bayer Crop Science, and Syngenta collectively operate large-scale DH production facilities across the Corn Belt, with DH lines constituting the majority of inbred germplasm released annually in commercial maize breeding pipelines. The proximity of world-class academic DH research centers, including Iowa State University, the University of Illinois, and Cornell University, to commercial operations facilitates rapid technology transfer and continuous protocol refinement. Regulatory clarity around non-transgenic gene-edited crops under the USDA SECURE Rule is accelerating the commercial integration of HI-Edit technology into North American commercial breeding programs, creating incremental growth in the highest-value subsegment of the market.

The Europe haploid induction technology for seed breeding market accounted for USD 121 million in 2025 and is anticipated to show lucrative growth over the forecast period.

Europe maintains a sophisticated and commercially mature DH technology ecosystem, particularly in canola/rapeseed, sunflower, and Brassica vegetable breeding, where European seed companies have been early adopters and innovators of microspore culture and in vitro DH protocols. Germany hosts several of the world’s leading DH research programs, including the University of Hohenheim’s renowned DH center, and serves as European headquarters for KWS SAAT SE, Bayer Crop Science, and BASF SE (Nunhems). The Netherlands serves as the center of the European vegetable seed industry, with Rijk Zwaan and other Dutch seed companies deeply integrating DH into pepper, tomato, and cucumber breeding programs. France, Spain, and Italy are important markets for sunflower and vegetable seed DH services, with regional contract DH providers including Procera (Romania) serving medium-sized seed companies across the continent.

Asia Pacific haploid induction technology for seed breeding market accounted for 27% market share in 2025 and is anticipated to show lucrative growth over the forecast period.

Asia Pacific is the second-largest and fastest-growing major regional market, driven by the scale of rice and wheat improvement programs in China, India, Japan, and South Korea and the rapid expansion of hybrid vegetable seed industries across the region. China’s state-funded crop improvement programs are the dominant demand driver, with national breeding centers under the Chinese Academy of Agricultural Sciences integrating anther culture and microspore culture protocols into wheat, rice, and maize improvement programs at national scale. India’s Green Revolution 2.0 agenda, prioritizing wheat and rice yield improvements through modern biotechnology tools, is creating new institutional demand for DH-assisted breeding. Japan and South Korea are significant markets for high-value vegetable DH services, supported by leading seed companies including Sakata Seed Corporation and Takii Seeds, with Australia emerging as a growing market for canola and barley DH program outsourcing.

Latin America haploid induction technology for seed breeding market is anticipated to grow at a CAGR of 10.8% during the analysis timeframe.

Latin America represents a growing market for haploid induction technology for seed breeding, underpinned by the region’s position as a major global producer of maize and soybean and the active expansion of commercial hybrid seed programs in Brazil, Argentina, and Mexico. CIMMYT’s Latin American research network, centered in Mexico, provides a critical institutional foundation for DH protocol development and capacity building, with active DH programs for maize and wheat targeted at improving productivity for smallholder and commercial farmers. Brazil is the dominant national market, driven by the scale of its commercial seed industry and the increasing adoption of DH line production by domestic seed companies and multinational subsidiaries. Government-supported crop improvement programs through Embrapa are also integrating DH tools into national wheat and soybean improvement pipelines.

Middle East & Africa haploid induction technology for seed breeding market is expected to grow at a CAGR of 13.8% during the analysis timeframe.

The Middle East and Africa region represents the smallest but fastest-growing regional market, driven by emerging investments in agricultural modernization and food security in South Africa, Saudi Arabia, the UAE, and Ethiopia. South Africa is the most commercially developed DH market in the region, supported by a significant commercial maize seed industry and the presence of international seed company operations including Bayer Crop Science and Corteva Agriscience. Saudi Arabia and the UAE are investing in DH-enabled crop improvement as part of broader agricultural self-sufficiency strategies, with government-funded research institutes exploring DH applications for locally adapted wheat, barley, and vegetable crops. Sub-Saharan African nations are increasingly benefiting from CIMMYT-led DH capacity-building programs targeting drought-tolerant maize improvement for smallholder farmers, creating incremental market development.

Haploid Induction Technology for Seed Breeding Market Share

• Corteva Agriscience, Syngenta AG, Bayer Crop Science, KWS SAAT SE & Co. KGaA, and Limagrain are significant participants in the global haploid induction technology for seed breeding market, collectively holding approximately 58% of the technology and service market share in 2025. The market exhibits a fragmented structure in the service segment, with large multinationals dominating in-house DH usage while specialist technology and service providers compete in the contract DH segment.
• Participants in the market are focusing on the continuous development and commercialization of advanced DH platforms, particularly integrating CRISPR-based gene editing with haploid induction to create differentiated technology capabilities. The commercial adoption of HI-Edit technology is becoming a key strategic differentiator among leading players, with first-mover advantages available in crops beyond maize where HI-Edit protocols are still being established.
• Product portfolio expansion across additional crop species beyond maize into wheat, rice, canola, and vegetable crops is a central strategy as companies seek to address the full breadth of commercial breeding demand. This multi-crop capability expansion is increasing the total addressable market accessible through DH service and platform licensing models.
• Strategic partnerships between large commercial seed companies and specialist DH service providers are increasing, reflecting the outsourcing trend where technology owners maintain protocol and IP ownership while scaling production through contracted capacity. These partnerships are reinforcing the competitive position of both parties in the evolving market structure.
• Investment in proprietary inducer line development, particularly for in vivo haploid induction systems with enhanced induction rates and broader germplasm applicability, remains a significant area of competitive differentiation. Inducer lines developed and maintained by market leaders represent substantial barriers to entry in the in vivo DH segment.
• Digital transformation of DH workflows, including AI-assisted haploid identification, predictive analytics for protocol optimization, and integrated breeding management platforms, is being prioritized by leading players to enhance operational efficiency and service quality for commercial seed company clients.
• Intellectual property strategies, including patent portfolios covering inducer lines, CRISPR-DH integration methods, and novel doubling agent formulations, are being actively expanded as market leaders seek to protect competitive advantages in the rapidly innovating technology landscape.

• Expansion of geographic presence in high-growth markets, particularly Asia Pacific and Latin America, is being pursued through direct investment in regional service centers and strategic alliances with local seed companies and government research programs.

Haploid Induction Technology for Seed Breeding Market Companies

The major players operating in the haploid induction technology for seed breeding industry include:

• Corteva Agriscience
• Syngenta AG
• Bayer Crop Science
• BASF SE (Nunhems)
• Limagrain
• KWS SAAT SE & Co. KGaA
• Sakata Seed Corporation
• Rijk Zwaan
• Fytagoras
• ScreenSYS
• Haplotech Inc.
• CIMMYT
• Iowa State University DH Facility
• University of Hohenheim DH Program
• Procera (Romania)

Corteva Agriscience maintains its position as a global leader in double haploid technology through its proprietary in vivo haploid induction system and the commercial development of HI-Edit technology, enabling precision-edited inbred line production within a single breeding generation. The company leverages its scale in maize and canola breeding to drive continuous improvement in DH protocol efficiency and genomic integration across its global breeding network.

Syngenta AG sustains its competitive standing through deep investment in both in vivo and in vitro DH platforms across maize, wheat, and vegetable crop species, coupled with the integration of molecular marker technologies that enable parallel selection of target traits during DH line development. Its global breeding network provides broad geographic coverage for DH operations across North America, Europe, and Asia Pacific.

Bayer Crop Science reinforces its market position through integrated DH capabilities across canola, soybean, cotton, and vegetable seed programs, maintaining proprietary inducer lines and chromosome doubling protocols optimized for diverse germplasm pools. The company’s investment in digital breeding platforms is enabling AI-assisted haploid identification and protocol optimization within its global breeding operations.

KWS SAAT SE & Co. KGaA maintains competitive relevance through the continuous development of improved haploid inducer lines for maize and sugar beet, with protocols that achieve consistently high induction rates across diverse adapted germplasm. The company’s European-rooted operational expertise supports strong market positioning in the canola, sugar beet, and winter wheat DH segments.

Limagrain positions itself through multi-crop DH capabilities spanning maize, wheat, sunflower, and vegetable seed breeding, leveraging its cooperative ownership structure to maintain long-term investment in DH platform development. Its strong position in European small grain cereals DH applications provides differentiated competitive capability in the wheat and barley breeding market.

Haploid Induction Technology for Seed Breeding Industry News

• In March 2025, Corteva Agriscience announced the commercial integration of its HI-Edit platform into its maize breeding program, representing a significant milestone in the commercialization of simultaneous haploid induction and CRISPR-mediated gene editing technology for rapid inbred line development. This marks a major commercial transition of DH-gene editing from research concept to active breeding pipeline deployment at scale.

• In October 2024, KWS SAAT SE & Co. KGaA disclosed the development of next-generation haploid inducer lines for winter wheat with a haploid induction rate exceeding 12%, representing a significant advance in in vivo DH protocol applicability for small grain cereal breeding programs. This development is expected to materially expand the commercial adoption of in vivo DH in European and North American wheat breeding programs.

The haploid induction technology for seed breeding mareket research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue (USD Million) from 2022 to 2035, for the following segments:

Click here to Buy Section of this Report

By Technology Type

• In Vivo Haploid Induction
• In Vitro Haploid Induction
• Gene Editing-Enabled HI (HI-Edit/IMGE)
• Haploid Screening & ID Tools
• Chromosome Doubling Agents

By Application

• DH Line Development
• HI-Edit / IMGE
• CMS Line Development
• Reverse Breeding
• Synthetic Apomixis
• Research & Functional Genomics

By Crop Type

• Cereals & Grains
• Oilseeds & Pulses
• Vegetables & Specialty Crops
• Others

By End User

• Commercial Seed Companies
• Public Research Institutions
• Government Agricultural Programs
• DH Contract Service Providers

The above information is provided for the following regions and countries:

North America

• U.S.
• Canada

Europe

• Germany
• France
• UK
• Netherlands
• Spain
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa